Morgan Lewis

Life Sciences Upcoming Events

For More Information

Read the Brochure

Life Sciences and Healthcare

Life Sciences Deskbook

New Resource

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Industry Events


Practice Highlights

Honors

PLCCross-border Quarterly 2011/12 Life Sciences Legal Market Review

  • Life Sciences Regulatory Super League - Ranked 10th of law firms worldwide

PLCCross-border Life Sciences Handbook 2011/12

  • U.S.:
    • Commercial and Partnering - Highly Recommended
    • Competition/Antitrust - Highly Recommended
    • Corporate - Recommended
    • Government Enforcement and Investigations - Highly Recommended
    • Regulatory - Recommended
    • Regulatory (Medical Devices) - Recommended
  • England: Regulatory - Recommended
  • Japan: Corporate and Commercial - Recommended

Chambers Global 2011: Global Life Sciences - Recommended - Band 3

Chambers USA 2011: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3

UK Legal 500 2010: London: Pharmaceuticals and Biotechnology

Best Lawyers in America 2011: Biotechnology and Healthcare Law Named

BioPharm Insight 2011
(based on last 12 months)

  • Ranked 1st in Legal Advisers on Asia-Pacific Licensing Agreements - Based on Volume
  • Ranked 4th in Legal Advisers on European Licensing Agreements - Based on Volume
  • Ranked 5th in Global League Table of Legal Advisers on Licensing Agreements - Based on Volume
  • Ranked 5th in Global League Table of Legal Advisers on Licensing Agreements - Based on Value
(based on Q1 2011)
  • Ranked 4th in Global League Table of Legal Advisers on Licensing Agreements - Based on Volume
  • Ranked 5th in Global League Table of Legal Advisers on Licensing Agreements - Based on Value
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

9 of the top 20 medical device companies

Related Events

02/27/12-02/29/12 ACI’s 16th Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions New York
Fahd Riaz, panelist, "Preparing Your IP for M&A or Product License: What Savvy Buyers Look For"
02/29/12-03/02/12 2012 IMS Managed Markets Services/DataNiche Conference Las Vegas, NV
Donna Lee Yesner, speaker
03/22/12-03/24/12 ABA Section of Business Law Spring Meeting 2012 Las Vegas, NV
Arianne Callender, panelist, "New and Evolving Threats from the Responsible Corporate Officers Doctrine"
View all events

Related News

01/04/12 Former VP and Deputy GC of Cephalon Joins Morgan Lewis
Morgan Lewis today announces that Steven A. Reed has joined the firm as a partner in its Litigation Practice, resident in Philadelphia.
01/20/11 Morgan Lewis Advises Perrigo on $540 Million Acquisition of Paddock Assets
Morgan Lewis advised Perrigo Company, a global healthcare products supplier, on its acquisition of nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash.
10/29/10 Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare
In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.
View all news

Related Publications

02/06/12 CMS Proposes Major Changes to AMP Rule
The Proposed Rule provides provisions that will significantly impact pharmaceutical manufacturers' rebate liability, price reporting calculations, and possibly their operations.
02/03/12 Class Action Arbitration Waiver Rejected by Federal Appellate Court
Second Circuit sidesteps Concepcion and holds that the ability to enforce federal statutory rights mandates that a plaintiff be allowed to pursue a class action in court notwithstanding the parties' agreement to mandatory arbitration.
01/25/12 2011 American Health Lawyer’s Association Annual Meeting
View all publications
Title Event Type Start Date End Date
ACI’s 16th Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions
Fahd Riaz, panelist, "Preparing Your IP for M&A or Product License: What Savvy Buyers Look For"		 Conferences and Speeches 02/27/2012 02/29/2012
2012 IMS Managed Markets Services/DataNiche Conference
Donna Lee Yesner, speaker		 Conferences and Speeches 02/29/2012 03/02/2012
ABA Section of Business Law Spring Meeting 2012
Arianne Callender, panelist, "New and Evolving Threats from the Responsible Corporate Officers Doctrine"		 Conferences and Speeches 03/22/2012 03/24/2012
National Hospice and Palliative Care Organization (NHPCO) 27th Management and Leadership Conference
Howard Young, panelist, "The OIG and Hospice in Nursing Facilities: Past, Present and Future"		 Conferences and Speeches 03/29/2012 03/31/2012
HCCA's 16th Annual Compliance Institute
Howard Young, speaker, "Handling a Health Care Fraud Investigation"		 Conferences and Speeches 04/29/2012 01:30 PM 04/29/2012 04:30 PM
2012 Health Law Institute in Minneapolis
Arianne Callender, speaker, "Fraud and Abuse Update"		 Conferences and Speeches 06/06/2012 06/07/2012